无菌检测设备验证:IQ、OQ与PQ框架综述
随着先进疗法发展,临床微生物实验室收到更多产品无菌检测请求,但此类检测受美国FDA的cGMP监管,与CMS临床要求不同。本文综述cGMP质量体系中设备、软件和系统的安装、运行与性能确认(IQ、OQ、PQ或IOPQ)框架,并与CAP要求比较,以血培养系统、控温单元和实验室信息管理系统为例,总结FDA相关引用。
要点
- cGMP设备验证包括IQ、OQ和PQ,临床实验室常忽视IQ和OQ。
- CAP phase II要求COM.30550和COM.30575涉及设备验证,但与cGMP不同。
- IOPQ要求也适用于2025年3月31日裁决废除前归类为器械的LDT。
核心结论
- 临床实验室开展cGMP无菌检测时,需重视设备、软件和系统的IOPQ验证,其要求与CAP规定存在差异。
研究设计与样本
- 本文为小型综述,概述cGMP设备验证的IOPQ框架,比较CAP要求,并总结FDA引用,以血培养系统、控温单元和实验室信息管理系统为例。
主要发现
- 临床实验室对IOPQ术语不熟悉,IQ和OQ部分常被忽视、未执行或未记录,尽管存在CAP phase II要求(COM.30550和COM.30575)。
关键数值与推荐
- CAP phase II要求包括COM.30550和COM.30575;IOPQ要求也适用于2025年3月31日裁决废除前归类为器械的LDT。
临床怎么用
- 临床实验室在开展cGMP无菌检测时,应按照IOPQ框架对设备、软件和系统进行验证并记录。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Product sterility testing requests are becoming increasingly common in clinical microbiology laboratories due to the rapid development of advanced therapies. Most laboratory directors are hesitant to bring on such tests because they fall under current Good Manufacturing Practices (cGMP) regulated by the United States Food and Drug Administration (FDA), where expectations differ from clinical requirements (regulated by the Centers for Medicare and Medicaid Services). When considerations are made for cGMP testing in the clinical lab, most focus is placed on analytical test validation. In this mini-review, we provide an overview of one critical element within the cGMP quality system-validation of equipment, software, and systems through installation, operational, and performance qualification (IQ, OQ, and PQ or IOPQ). This terminology is not common in clinical laboratories, and the IQ and OQ portions are often overlooked, not performed, and/or not documented, although phase II CAP requirements exist (COM.30550 and COM.30575). This mini-review will provide an overview of the IOPQ framework, what is included and how it differs from CAP requirements, important considerations for an IOPQ, and a summary of FDA citations relating to equipment validation. We provide examples using blood culture systems, controlled temperature units (CTUs; e.g., incubator), and the laboratory information management system, given their likelihood for use in cGMP activities in the clinical lab. Importantly, the IOPQ requirements summarized here would have also been relevant to laboratory-developed tests (LDTs) classified as "devices" prior to the March 31, 2025, annulment of the ruling.
引用
- Gebo JET, Feehely KM, Lattimore CE, et al. All you need to know about equipment validation for sterility testing. J Clin Microbiol. 2025. PMID: 40788093. doi:10.1128/jcm.01477-24
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。